5 studies found for:    thyroid AND surgery AND Northwestern
Show Display Options
Rank Status Study
1 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
2 Recruiting Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: efatutazone;   Drug: paclitaxel
3 Active, not recruiting
Has Results
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
Condition: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Interventions: Biological: Nivolumab;   Drug: Everolimus
4 Completed
Has Results
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer [F];   Advanced Breast Cancer;   Metastatic Castration Resistant Prostate Cancer;   Metastatic Renal Cell Cancer;   Non-Small Cell Lung Cancer;   Thyroid Cancer;   Advanced/Metastatic Non-Small Cell Lung Cancer;   Advanced Gastric Cancer;   Gastrointestinal Stromal Tumor;   Hepatocellular Carcinoma;   Pancreatic Islet Cell Carcinoma;   Pancreatic Neuroendocrine Tumor
Intervention: Drug: sunitinib
5 Completed The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Teplizumab;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.